Lumify PF Generic: When Will Generic Brimonidine Be Available?

Dr. Brian Staiger, PharmD, BCPS

This page is aggregated from FDA records, court filings and company announcements. Coded and designed by

Updated October 9, 2026 How we build our data

Lumify PF Generic at a Glance

Four quick answers from FDA records and our estimate.

  1. When is the first generic expected? July to December 2027 A 6-month window Why then?
  2. Has the FDA approved a generic? Unknown No FDA Orange Book record under this name
  3. When does the brand’s protection end? Unknown Not in the FDA record we could read
  4. Can you buy a generic today? Yes 14 companies list one

Explains

PharmD, BCPS · Clinical pharmacist Updated

It already is. A generic brimonidine tartrate is listed for sale by 14 companies, so ask your pharmacy whether it can fill your prescription with one.

Why July to December 2027?

The patent fight is likely to end in an agreement that sets the launch. The terms are not public yet. We rate it toss-up: still unsettled. Just as likely to slip as to hold.

What should I do now?

Ask your pharmacy whether it can fill your prescription with a generic. It may look different from Lumify PF, but the active ingredient, strength and form are the same. What a generic means for you

Our month is only an estimate based on available information, so we never name a day.

Lumify PF by the Numbers

Reason
Settlement expectedThe patent fight is likely to end in an agreement that sets the launch. The terms are not public yet.
How sure
Toss-up Still unsettled. Just as likely to slip as to hold.
Price competition
None filed yet No filers on record
Brand sales
Sales not reported

Lumify PF’s Road to a Generic

The first generic of Lumify PF is expected between July and December 2027.

Why that month: the patent fight is likely to end in an agreement that sets the launch. The terms are not public yet.

Brand alone on the market Approval date not in the Orange Book
Brand alone on the market First generic expected Swipe the chart sideways to see every year.

The bar shows Lumify PF on the market on its own until the month we expect the first generic (the green band), a month and never a day. Its approval date and patents are not in the FDA Orange Book under this name, so the bar fades in from the left. The expected month comes from court records and company announcements.

Who Is Lined Up to Make Generic Brimonidine Tartrate

Three steps stand between a brand and a generic you can buy: a company applies to the FDA, the FDA approves it, and the company starts selling it.

1

Applied to the FDA

No company is recorded as having applied to the FDA to make a generic Lumify PF yet.

2

Approved by the FDA

We could not find Lumify PF’s own record in the FDA Orange Book under this name, so the approved generic makers are not shown.

3

For Sale in Pharmacies

Yes. A generic brimonidine tartrate is listed for sale by 14 companies. Ask your pharmacy whether it can fill your prescription with it.

A-S Medication Solutions, Akorn, Alembic Pharmaceuticals Inc., Alembic Pharmaceuticals Limited, Apotex Corp., Bausch & Lomb Incorporated and 8 more

Sources: how many companies have applied, from court records and company announcements; approved generics from the FDA Orange Book; what is for sale from the FDA NDC Directory. The FDA does not disclose an application before it approves it (21 CFR 314.430).

Lumify PF Price: What Pharmacies Pay and What Generics Usually Do

What a Generic Could Cost

How we estimate it. The national survey of what pharmacies pay (NADAC) has no recent price for Lumify PF, so we cannot show dollars. Here is the FDA’s finding of how far the price pharmacies pay usually falls as generic companies join: about 31% with one company, 44% with two, 73% with four and over 95% with six or more (the typical drop for every drug whose first generic came out from 2015 to 2017).

Median prices pharmacies paid for the generic (invoice prices), compared with the brand’s price before generic entry, from FDA’s 2019 analysis “Generic Competition and Drug Prices”. At the manufacturer’s price FDA found steeper drops (about 39%, 54%, 79% and over 95%), the figures quoted elsewhere on this tracker. A typical pattern, not a price quote for this medicine.

What a Generic Lumify PF Means for You

Nothing Changes Until It Is in Pharmacies

A generic is listed for sale now, so your pharmacy may already be able to fill your prescription with it.

Your Pharmacy May Switch You Automatically

Every state lets pharmacists fill a brand-name prescription with an FDA-approved generic rated as equivalent to it, and about 19 states require them to, unless your prescriber writes “dispense as written” or “brand medically necessary” on the prescription. Some states ask the pharmacist to tell you, or to get your OK first. A study of every state’s law has the details.

It Will Probably Look Different

US trademark law does not let a generic look exactly like the brand, so the color, shape or markings usually change. The active ingredient, strength and form are the same. An “authorized generic,” made by or for the brand’s own company, can look identical. The FDA explains.

Your Insurance May Change Too

Once a lower-cost version is available, many insurance plans charge more for the brand, or stop covering it. Your plan’s drug list (formulary) says how.

Questions people ask about Lumify PF

Is there a generic for Lumify PF right now?

Yes. The FDA NDC Directory lists a generic brimonidine tartrate from 14 companies. Ask your pharmacy whether it can fill your prescription with it.

When will Lumify PF go generic?

It already has. The FDA NDC Directory lists a generic brimonidine tartrate from 14 companies, so ask your pharmacy whether it can fill your prescription with one.

Will generic brimonidine tartrate be the same as Lumify PF?

Yes in the ways that matter: the same active ingredient, strength and form, with proof that it reaches your blood the same way. Inactive ingredients can differ, which is why some people notice a different look or taste.

How much will the generic cost?

Nobody can say for sure before launch. No company is recorded as having applied to the FDA to make one yet, and a single company usually brings only a modest drop.

Changes to This Projection

  • First generic expected July to December 2027 on this month’s schedule. A line is added here whenever a monthly update moves the month, the reason or how sure it is.

Every change to the expected month is logged here with the month we saw it.

Also Going Generic

All upcoming generics

About Lumify PF

Sources. The expected month: FDA Paragraph IV Patent Certifications list, federal court records, company announcements and securities filings (settlement dates, launch plans, sales). The record on this page: FDA Orange Book, FDA NDC Directory, FDA, Generic Competition and Drug Prices (2019). Updated October 9, 2026. Information, not medical advice.